Lombard Odier's Strategic Portfolio Adjustments
Lombard Odier Trims U.S. Equity Holdings Across Several Major Stocks in Q1
Anonymous
Key Points
1
Bruker Corporation: Lombard Odier Europe Ltd sold 70,008 shares in Q1, reducing its stake by 51.4% to 66,216 shares, with the quarter-end holding valued at about $2.392 million. Notably, 79.52% of Bruker’s stock is owned by hedge funds and other institutional investors.
2
Jack Henry & Associates: Lombard Odier Europe Ltd cut its stake by 30.6% to 12,500 shares after selling 5,500 shares, with the position valued at about $1.976 million. The filing also shows a flurry of activity from other institutions, including Northwest & Ethical Investments L.P., Lansforsakringar Fondforvaltning AB publ, DNB Asset Management AS, Schroder Investment Management Group, and others adjusting positions in the period.
3
Crescent Energy: Lombard Odier USA Corp reduced its holdings by 37.9% to 87,000 shares (after selling 53,000), valued at about $1.174 million. Other major holders increased or rebalanced, with Vanguard Group Inc. boosting its Crescent Energy stake by 34.6% to over 27 million shares, and several other large managers (Dimensional Fund Advisors, State Street, Geode, Charles Schwab) also expanding positions.
4
Colgate-Palmolive: Europe-based holdings lowered by 44.0% to 96,923 shares, valued at approximately $8.261 million, with institutional ownership still high (80.41%). The company also faced ongoing coverage from multiple research firms, including Deutsche Bank, reflecting an active research milieu around the stock.
5
Cencora: Lombard Odier USA Corp reduced its stake by 31.8% to 4,171 shares, worth about $1.31 million. The stock remains predominantly held by institutions (about 97.52%), with notable moves from other big players including T. Rowe Price Investment Management (up 160.1% to 6.7 million shares), Norges Bank initiating a new stake, Marshall Wace, UBS Asset Management, and Viking Global Investors among others.
Lombard Odier Asset Management quietly trimmed stakes across a broad swath of U.S. equities in the first quarter of 2025. The Swiss firm's two main arms — Europe Ltd and USA Corp — shed positions in at least five notable stocks, with cuts ranging from 30% to more than 51%, according to Watchlist News.
The selloff touched a wide range of sectors, from healthcare technology to consumer staples to energy. No single position was eliminated outright, but each was meaningfully reduced. The largest dollar-value holding cut was in Colgate-Palmolive, trimmed by 44% to a stake worth roughly $8.3 million.
Bruker and Jack Henry See the Deepest Percentage Cuts
The sharpest cut came in Bruker Corporation. Lombard Odier Europe Ltd sold 70,008 shares in Q1, slashing its stake by 51.4%. That left it holding just 66,216 shares, worth about $2.39 million, according to Watchlist News. Bruker makes scientific instruments. Nearly 80% of its stock is held by hedge funds and other big institutions.
Jack Henry & Associates also saw a meaningful trim. Lombard Odier Europe Ltd sold 5,500 shares, cutting its position by 30.6% to 12,500 shares. That stake was worth about $1.98 million at quarter-end. Several other institutions — including Schroder Investment Management and DNB Asset Management — also shifted their Jack Henry positions during the same period, per Watchlist News.
Colgate-Palmolive Reduction Carries the Biggest Dollar Impact
Colgate-Palmolive was the largest position Lombard Odier cut in raw dollar terms. The Europe arm sold enough shares to lower its stake by 44%, leaving it with 96,923 shares valued at roughly $8.26 million. Institutional ownership in Colgate remains high at about 80%, per Watchlist News. Deutsche Bank is among the research firms actively covering the stock.
Crescent Energy and Cencora Round Out the Cuts
In energy, Lombard Odier USA Corp sold 53,000 shares of Crescent Energy, reducing its position by 37.9% to 87,000 shares worth about $1.17 million. The firm trimmed even as larger players moved in the opposite direction. Vanguard Group boosted its Crescent Energy stake by 34.6%, bringing its total to over 27 million shares, according to Watchlist News.
Cencora saw a 31.8% cut from Lombard Odier USA Corp, leaving just 4,171 shares worth about $1.31 million. The drug distributor remains overwhelmingly institutional — roughly 97.5% of shares are held by big money managers. T. Rowe Price Investment Management bucked the selling trend, growing its own Cencora stake by 160.1% to 6.7 million shares in the same period, per Watchlist News.
A Pattern of Quiet Rebalancing, Not Panic Selling
Lombard Odier did not exit any of these positions fully. Each remaining stake still runs into the millions of dollars. The moves look more like routine portfolio trimming than a hard pivot away from U.S. equities. The firm also sold shares in RBC Bearings and Birkenstock and cut its Crown Holdings position by 31.7%, per Watchlist News, suggesting a broader first-quarter rebalancing effort.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
16
Reach
30
A
AnonymousAuthor
